ID   HEV0240
AC   CVCL_T193
DR   RCB; HEV0240
DR   Wikidata; Q54883085
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese and Korean.
CC   HLA typing: A*24:02; B*48:01,52:01; C*08:01,12:02; DPB1*02:01,09:01; DQB1*06:01,06:02; DRB1*15:01,15:02 (RCB=HEV0240).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
RX   PubMed=16260175; DOI=10.1016/j.mrgentox.2005.07.012;
RA   Iwakawa M., Goto M., Noda S., Sagara M., Yamada S., Yamamoto N.,
RA   Kawakami Y., Matsui Y., Miyazawa Y., Yamazaki H., Tsuji H., Ohno T.,
RA   Mizoe J., Tsujii H., Imai T.;
RT   "DNA repair capacity measured by high throughput alkaline comet assays
RT   in EBV-transformed cell lines and peripheral blood cells from cancer
RT   patients and healthy volunteers.";
RL   Mutat. Res. 588:1-6(2005).
//
RX   PubMed=38639832; DOI=10.1007/s13577-024-01055-0; PMCID=PMC11194210;
RA   Kasai F., Fukushima M., Miyagi Y., Nakamura Y.;
RT   "Genetic diversity among the present Japanese population: evidence
RT   from genotyping of human cell lines established in Japan.";
RL   Hum. Cell 37:944-950(2024).
//